119 related articles for article (PubMed ID: 20041956)
1. Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes.
Alvarez S; Mas S; Gassó P; Bernardo M; Parellada E; Lafuente A
Fundam Clin Pharmacol; 2010 Dec; 24(6):741-7. PubMed ID: 20041956
[TBL] [Abstract][Full Text] [Related]
2. Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans.
Treister R; Pud D; Ebstein RP; Laiba E; Gershon E; Haddad M; Eisenberg E
Pain; 2009 Dec; 147(1-3):187-93. PubMed ID: 19796878
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes.
Gassó P; Mas S; Crescenti A; Alvarez S; Parramon G; Garcia-Rizo C; Parellada E; Bernardo M; Lafuente A
Psychiatry Res; 2010 Jan; 175(1-2):173-5. PubMed ID: 19892410
[TBL] [Abstract][Full Text] [Related]
4. [Lack of association between VNTR polymorphism of DAT gene and schizophrenia].
Hauser J; Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Twardowska K; Rybakowski JK
Psychiatr Pol; 2002; 36(3):403-12. PubMed ID: 12149916
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis.
Norton N; Kirov G; Zammit S; Jones G; Jones S; Owen R; Krawczak M; Williams NM; O'Donovan MC; Owen MJ
Am J Med Genet; 2002 Jul; 114(5):491-6. PubMed ID: 12116182
[TBL] [Abstract][Full Text] [Related]
7. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
[TBL] [Abstract][Full Text] [Related]
8. Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers.
Jeong SH; Joo EJ; Ahn YM; Kim YS
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):975-83. PubMed ID: 15380858
[TBL] [Abstract][Full Text] [Related]
9. Association of A/G polymorphism in intron 13 of the monoamine oxidase B gene with schizophrenia in a Spanish population.
Gassó P; Bernardo M; Mas S; Crescenti A; Garcia C; Parellada E; Lafuente A
Neuropsychobiology; 2008; 58(2):65-70. PubMed ID: 18832861
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between dopamine transporter gene polymorphisms and delusional disorder.
Persico AM; Catalano M
Am J Med Genet; 1998 Mar; 81(2):163-5. PubMed ID: 9613856
[TBL] [Abstract][Full Text] [Related]
11. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence.
Samochowiec J; Kucharska-Mazur J; Grzywacz A; Jabłoński M; Rommelspacher H; Samochowiec A; Sznabowicz M; Horodnicki J; Sagan L; Pełka-Wysiecka J
Neurosci Lett; 2006 Dec; 410(1):1-5. PubMed ID: 17079080
[TBL] [Abstract][Full Text] [Related]
12. Low frequency of CYP2D6 poor metabolizers among schizophrenia patients.
Llerena A; Dorado P; Peñas-Lledó EM; Cáceres MC; De la Rubia A
Pharmacogenomics J; 2007 Dec; 7(6):408-10. PubMed ID: 17325735
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
[TBL] [Abstract][Full Text] [Related]
14. [Case-control, family based and screening for DNA sequence variation in the dopamine transporter gene polymorphism DAT 1 in alcohol dependence].
Grzywacz A; Samochowiec J
Psychiatr Pol; 2008; 42(3):443-52. PubMed ID: 19899571
[TBL] [Abstract][Full Text] [Related]
15. Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: a preliminary finding.
Mihara K; Kondo T; Higuchi H; Takahashi H; Yoshida K; Shimizu T; Kaneko S
Am J Med Genet; 2002 Aug; 114(6):693-5. PubMed ID: 12210290
[TBL] [Abstract][Full Text] [Related]
16. [Association study of the polymorphisms of monoamine oxidase A genes with schizophrenia].
Shi YZ; Wang CH; Lv LX; Wang YH; Zhang HX; Lou BY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):457-9. PubMed ID: 17680543
[TBL] [Abstract][Full Text] [Related]
17. Association study between antipsychotic-induced restless legs syndrome and polymorphisms of monoamine oxidase genes in schizophrenia.
Kang SG; Park YM; Choi JE; Lim SW; Lee HJ; Lee SH; Kim YK; Kim SH; Cho SN; Kim L
Hum Psychopharmacol; 2010 Jul; 25(5):397-403. PubMed ID: 20589923
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 2D6 polymorphism and character traits.
Suzuki E; Kitao Y; Ono Y; Iijima Y; Inada T
Psychiatr Genet; 2003 Jun; 13(2):111-3. PubMed ID: 12782969
[TBL] [Abstract][Full Text] [Related]
19. Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan.
Wang TJ; Huang SY; Lin WW; Lo HY; Wu PL; Wang YS; Wu YS; Ko HC; Shih JC; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):108-14. PubMed ID: 17007976
[TBL] [Abstract][Full Text] [Related]
20. [Functional polymorphism of genes inactivating catecholamines and emotional deficits in paranoid schizophrenia].
Tylec A; Kucharska-Pietura K; Jeleniewicz W; Czernikiewicz A; Stryjecka-Zimmer M
Psychiatr Pol; 2010; 44(2):207-19. PubMed ID: 20677440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
